e-Therapeutics appoints Daniel Elger as CFO
This article was originally published in Scrip
Dr Daniel Elger has joined e-Therapeutics, a network pharmacology company focused on drug discovery and development, as chief financial officer. Dr Elger was previously vice-president of marketing and communications at cancer drug developer Antisoma. He joins as John Cordiner, the company's finance director, has resigned to pursue other business interests.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.